Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.

Dall R, Longobardi S, Ehrnborg C, Keay N, Rosén T, Jørgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sönksen PH.

J Clin Endocrinol Metab. 2000 Nov;85(11):4193-200.

PMID:
11095453
2.

Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.

de Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E.

J Clin Endocrinol Metab. 1996 Apr;81(4):1371-7.

PMID:
8636336
3.
4.
5.

No influence of prednisolone on IGFBP-3 proteolysis in healthy young men.

Dall R, Wolthers T, Flyvbjerg A, Grøfte T, Sandahl Christiansen J, Jørgensen JO.

Horm Res. 2001;55(2):95-101.

PMID:
11509866
6.

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Drake WM, Coyte D, Camacho-Hübner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP.

J Clin Endocrinol Metab. 1998 Nov;83(11):3913-9.

PMID:
9814468
7.

Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.

Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.

J Clin Endocrinol Metab. 1999 Nov;84(11):4118-26.

PMID:
10566659
9.

Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.

Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.

Am J Physiol Endocrinol Metab. 2006 May;290(5):E1006-13. Epub 2006 Jan 3.

10.

Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.

Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.

J Clin Endocrinol Metab. 2001 Mar;86(3):1091-8.

PMID:
11238491
11.
12.

Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.

Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.

J Clin Endocrinol Metab. 2001 Jul;86(7):3001-8.

PMID:
11443159
13.

A low starting dose of genotropin in growth hormone-deficient adults.

Janssen YJ, Frölich M, Roelfsema F.

J Clin Endocrinol Metab. 1997 Jan;82(1):129-35.

PMID:
8989246
14.

Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.

Olivecrona H, Hilding A, Ekström C, Barle H, Nyberg B, Möller C, Delhanty PJ, Baxter RC, Angelin B, Ekström TJ, Tally M.

J Clin Endocrinol Metab. 1999 Feb;84(2):553-60.

PMID:
10022415
15.

Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.

Skjaerbaek C, Frystyk J, Møller J, Christiansen JS, Orskov H.

Eur J Endocrinol. 1996 Dec;135(6):672-7.

PMID:
9025711
16.

Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001. Epub 2008 Feb 20.

PMID:
18282776
17.

Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.

Gill MS, Toogood AA, Jones J, Clayton PE, Shalet SM.

J Clin Endocrinol Metab. 1999 Apr;84(4):1288-95.

PMID:
10199769
18.
19.

GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake.

Lange KH, Isaksson F, Rasmussen MH, Juul A, Bülow J, Kjaer M.

Clin Endocrinol (Oxf). 2001 Jul;55(1):77-86.

PMID:
11453955
20.

Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.

Tillmann V, Patel L, Gill MS, Whatmore AJ, Price DA, Kibirige MS, Wales JK, Clayton PE.

Clin Endocrinol (Oxf). 2000 Sep;53(3):329-36.

PMID:
10971450

Supplemental Content

Support Center